ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Eliem Therapeutics Inc

Eliem Therapeutics Inc (ELYM)

8.53
0.55
( 6.89% )
Updated: 12:38:55

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.53
Bid
8.51
Ask
8.55
Volume
186,314
7.95 Day's Range 8.60
2.35 52 Week Range 11.55
Market Cap
Previous Close
7.98
Open
8.22
Last Trade
43
@
8.51
Last Trade Time
12:38:26
Financial Volume
$ 1,528,078
VWAP
8.2016
Average Volume (3m)
254,139
Shares Outstanding
67,060,163
Dividend Yield
-
PE Ratio
-16.21
Earnings Per Share (EPS)
-0.52
Revenue
-
Net Profit
-35.12M

About Eliem Therapeutics Inc

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Eliem Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELYM. The last closing price for Eliem Therapeutics was $7.98. Over the last year, Eliem Therapeutics shares have traded in a share price range of $ 2.35 to $ 11.55.

Eliem Therapeutics currently has 67,060,163 shares outstanding. The market capitalization of Eliem Therapeutics is $535.14 million. Eliem Therapeutics has a price to earnings ratio (PE ratio) of -16.21.

ELYM Latest News

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel...

Eliem Therapeutics Announces Additions to its Leadership Team

Brett Kaplan, M.D. appointed Chief Operating Officer Nishi Rampal, M.D. appointed Senior Vice President, Clinical Development SEATTLE and CAMBRIDGE, United Kingdom, Aug. 26, 2024 (GLOBE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.698.801020408167.848.797.82777868.12720259CS
42.4540.29605263166.088.795.653452727.34369907CS
120.465.700123915748.079.215.512541397.33894926CS
265.82214.7601476012.7111.552.525716555.69155333CS
525.87220.6766917292.6611.552.352924585.63406887CS
156-9.46-52.584769316317.9920.912.211347735.82553458CS
260-7.72-47.507692307716.2529.692.211412507.01462972CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 5.74
(152.86%)
40.07M
ZEOZeo Energy Corporation
$ 2.3292
(104.32%)
53.49M
TBIOTelesis Bio Inc
$ 2.72
(100.00%)
41.45M
XCURExicure Inc
$ 3.84
(67.69%)
14.14M
GLMDGalmed Pharmaceuticals Ltd
$ 10.36
(50.14%)
29.96M
HAOHaoxi Health Technology Ltd
$ 0.7399
(-75.34%)
6.5M
XCHXCHG Ltd
$ 8.11
(-55.85%)
906.39k
GDHGGolden Heaven Group Holdings Ltd
$ 2.68
(-35.73%)
401.35k
BLMZBloomZ Inc
$ 0.9099
(-33.58%)
502.74k
HOVRNew Horizon Aircraft Ltd
$ 0.504
(-31.98%)
1.79M
NVDANVIDIA Corporation
$ 119.15
(5.10%)
160.94M
SQQQProShares UltraPro Short QQQ
$ 7.66
(-8.81%)
139.04M
MAXNMaxeon Solar Technologies Ltd
$ 0.1053
(15.84%)
74.99M
FRGTFreight Technologies Inc
$ 0.1308
(5.57%)
74.27M
TSLATesla Inc
$ 242.7749
(6.86%)
62.15M

Your Recent History

Delayed Upgrade Clock